Related Experiment Video
Updated: Nov 5, 2025

Microelectrode Array Recording of Sinoatrial Node Firing Rate to Identify Intrinsic Cardiac Pacemaking Defects in Mice
Published on: July 5, 2021
Does the Age of Sudden Cardiac Death in Family Members Matter in Brugada Syndrome?
Pattara Rattanawong1,2, Jakrin Kewcharoen3, Chanavuth Kanitsoraphan3
1Department of Cardiovascular Medicine Mayo Clinic Phoenix AZ.
Insights
A family history of sudden cardiac death (SCD) in Brugada syndrome patients does not increase major arrhythmic event (MAE) risk overall. However, SCD in family members under 40 significantly elevates MAE risk.
Area of Science:
- Cardiology
- Genetics
- Epidemiology
Background:
- Brugada syndrome is an inherited cardiac channelopathy linked to major arrhythmic events (MAEs).
- The role of a family history of sudden cardiac death (SCD) as a risk predictor for MAEs in Brugada syndrome patients is debated.
- Identifying accurate risk predictors is crucial for managing Brugada syndrome and preventing life-threatening arrhythmias.
Purpose of the Study:
- To systematically review and meta-analyze the association between family history of SCD and MAEs in Brugada syndrome.
- To investigate if the age of SCD in family members modifies the risk of MAEs.
- To provide evidence-based insights into risk stratification for Brugada syndrome patients.
Main Methods:
- Systematic review and meta-analysis of studies published between January 1992 and January 2020.
- Searched MEDLINE and EMBASE databases for relevant research.
- Combined data using random-effects models and performed metaregression to assess age-related risk.
Main Results:
- Twenty-two studies involving 3386 Brugada syndrome patients were included.
- Overall family history of SCD was not significantly associated with increased MAE risk (OR, 1.11; P=0.489).
- A history of SCD in family members younger than 40 years approximately doubled the risk of MAEs (OR, 2.03; P=0.022).
Conclusions:
- A family history of SCD is not a universal risk factor for MAEs in Brugada syndrome.
- However, SCD in younger family members (specifically under 40 years) is a significant risk factor for MAEs.
- Age stratification of SCD in family history is critical for accurate risk assessment in Brugada syndrome.
Abstract:
Background Brugada syndrome is an inherited cardiac channelopathy associated with major arrhythmic events (MAEs). The presence of a positive family history of sudden cardiac death (SCD) as a risk predictor of MAE remains controversial. We aimed to examine the association between family history of SCD and MAEs stratified by age of SCD with a systematic review and meta-analysis. Methods and Results We searched the databases of MEDLINE and EMBASE from January 1992 to January 2020. Data from each study were combined using the random-effects model. Fitted metaregression was performed to evaluate the association between the age of SCD in families and the risk of MAE. Twenty-two studies from 2004 to 2019 were included in this meta-analysis involving 3386 patients with Brugada syndrome. The overall family history of SCD was not associated with increased risk of MAE in Brugada syndrome (pooled odds ratio [OR], 1.11; 95% CI, 0.82-1.51; P=0.489, I2=45.0%). However, a history of SCD in family members of age younger than 40 years of age did increase the risk of MAE by ≈2-fold (pooled OR, 2.03; 95% CI, 1.11-3.73; P=0.022, I2=0.0%). When stratified by the age of cut point at 50, 45, 40, and 35 years old, a history of SCD in younger family member was significantly associated with a higher risk of MAE (pooled OR, 0.49, 1.30, 1.51, and 2.97, respectively; P=0.046). Conclusions A history of SCD among family members of age younger than 40 years was associated with a higher risk of MAE.
More Related Videos
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Decreased pulse rate
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease III: Clinical Manifestations
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy

